NCT04938245 Improving Spinal Cord Stimulation With ECAPS
| NCT ID | NCT04938245 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Minnesota |
| Condition | Chronic Pain |
| Study Type | OBSERVATIONAL |
| Enrollment | 15 participants |
| Start Date | 2021-08-18 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 15 participants in total. It began in 2021-08-18 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study will be to investigate the optimization of spinal cord stimulation with ECAPs in patients with spinal cord implants.
Eligibility Criteria
Inclusion Criteria: * Medically stable as determined by the principal investigator * Scheduled to undergo externalization of spinal cord stimulation * English-speaking Exclusion Criteria: * Scheduled for permanent implantation only without trial * Have pacemakers or other neurostimulators * Pregnancy
Contact & Investigator
David Darrow, MD, MPH
PRINCIPAL INVESTIGATOR
University of Minnesota Medical School Department of Neurosurgery
Frequently Asked Questions
Who can join the NCT04938245 clinical trial?
This trial is open to participants of all sexes, aged 22 Years or older, studying Chronic Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04938245 currently recruiting?
Yes, NCT04938245 is actively recruiting participants. Contact the research team at darro015@umn.edu for enrollment information.
Where is the NCT04938245 trial being conducted?
This trial is being conducted at Minneapolis, United States.
Who is sponsoring the NCT04938245 clinical trial?
NCT04938245 is sponsored by University of Minnesota. The principal investigator is David Darrow, MD, MPH at University of Minnesota Medical School Department of Neurosurgery. The trial plans to enroll 15 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.